Permeation of piroxicam from the poloxamer gels

被引:48
作者
Shin, SC [1 ]
Cho, CW
Choi, HK
机构
[1] Chonnam Natl Univ, Coll Pharm, Kwangju, South Korea
[2] Chosun Univ, Coll Pharm, Kwangju 501759, South Korea
基金
新加坡国家研究基金会;
关键词
D O I
10.1081/DDC-100102171
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Topical formulations of piroxicam were prepared using poloxamer 407 or poloxamer 188 by a cold method, and the permeation characteristics of piroxicam were evaluated. The permeation rate of piroxicam across the synthetic cellulose membrane and the rat skin decreased as the concentration of poloxamer increased. Though poloxamer gel exhibits reversed thermal behavior, the permeation rate of piroxicam increased with increasing temperature, indicating that the diffusional pathway of piroxicam is a water channel within the gel formulation. The pH of the gel did not affect the permeation rate of piroxicam significantly. As the concentration of piroxicam in the gel formulation increased, the permeation rate of piroxicam increased up to 1% and reached a plateau above 1%. Among various enhancers tested, polyoxyethylene-2-oleyl ether showed the highest enhancing effect, with an enhancement ratio of 2.84. Based on experimental results, the permeation rate of piroxicam can be controlled by changing the poloxamer concentration or drug concentration and by the addition of an appropriate enhancer.
引用
收藏
页码:273 / 278
页数:6
相关论文
共 12 条
[1]  
Al-Saden A. A., 1979, J PHARM PHARMACOL, V31, P81, DOI [10.1111/j.2042-7158.1979.tb11629.x, DOI 10.1111/J.2042-7158.1979.TB11629.X]
[2]   THE MICELLAR PROPERTIES OF THE POLY(OXYETHYLENE) POLY(OXYPROPYLENE) COPOLYMER PLURONIC-F127 IN WATER AND ELECTROLYTE SOLUTION [J].
ATTWOOD, D ;
COLLETT, JH ;
TAIT, CJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 26 (1-2) :25-33
[3]   LOGICS OF TRANSDERMAL CONTROLLED DRUG ADMINISTRATION [J].
CHIEN, YW .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1983, 9 (04) :497-520
[4]   DEVELOPMENT OF A DYNAMIC SKIN PERMEATION SYSTEM FOR LONG-TERM PERMEATION STUDIES [J].
CHIEN, YW ;
VALIA, KH .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1984, 10 (04) :575-599
[5]  
COLLETT JH, 1985, P INT S CONTROL REL, V12, P28
[6]   MASS-TRANSPORT PHENOMENA AND MODELS - THEORETICAL CONCEPTS [J].
FLYNN, GL ;
YALKOWSKY, SH ;
ROSEMAN, TJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (04) :479-510
[7]  
Higuchi T., 1960, J SOC COSMET CHEM, V11, P85
[8]  
HSUEHLING SW, 1990, INT J PHARM, V66, P213
[9]  
MIYAZAKI S, 1986, CHEM PHARM BULL, V34, P1801
[10]  
SCHIANTARELLI P, 1981, ARZNEIMITTEL-FORSCH, V31-1, P87